{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T00:59:01Z","timestamp":1794704341873,"version":"4.9.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Given the number of drugs available in the anaesthetist's armamentarium, drug interactions need to be managed. This is particularly true of psychoactive medications which primarily act on the central nervous system, targeting neurotransmitter pathways often affected by anaesthetic agents. This review gives an overview of the potential interactions of commonly used psychoactive medications with anaesthetic agents and hence their perioperative considerations. As anaesthetists will already be very familiar with the benzodiazepines, they will not be discussed here. Electroconvulsive therapy will also not be discussed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>A wide range of psychoactive medications can interact with drugs commonly used in perioperative care including anaesthetic agents. There is limited clinical research into their effects and hence these interactions are based on known pharmacological actions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>A cautious, pragmatic approach is recommended when managing patients on psychoactive medications requiring anaesthesia as part of their medical care.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aco.0000000000001041","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T18:14:37Z","timestamp":1627323277000},"page":"582-589","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Perioperative management considerations in patients taking prescribed psychoactive medications (including those for depression and Parkinson's disease)"],"prefix":"10.1097","volume":"34","author":[{"given":"Serene","family":"Ho","sequence":"first","affiliation":[{"name":"Cavendish Clinic London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Wong","sequence":"additional","affiliation":[{"name":"Consultant Critical Care and Anaesthesia, King's College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,7,22]]},"reference":[{"key":"R1-20250601","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bjp.0707253","article-title":"Tricyclic antidepressant pharmacology and therapeutic drug interactions updated","volume":"151","author":"Gillman","year":"2007","journal-title":"Br J Pharm"},{"key":"R2-20250601","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/bjaceaccp\/mkq037","article-title":"Anaesthetic implications of psychoactive drugs","volume":"10","author":"Peck","year":"2010","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"R3-20250601","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.mpaic.2010.12.012","article-title":"Antidepressants and antipsychotics: anaesthetic implications","volume":"12","author":"Rasool","year":"2011","journal-title":"Anaesth Intensive Care Med"},{"key":"R4-20250601","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2344\/anpr-64-04-14","article-title":"Anesthetic considerations for patients on antidepressant therapy \u2013 Part 1","volume":"64","author":"Saraghi","year":"2017","journal-title":"Anesth Prog"},{"key":"R5-20250601","doi-asserted-by":"crossref","first-page":"e2022","DOI":"10.1097\/MD.0000000000002022","article-title":"Use of SSRI, but not SNRI, increased upper and lower gastrointestinal bleeding","volume":"94","author":"Cheng","year":"2015","journal-title":"Medicine"},{"key":"R6-20250601","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/sj.bjp.0707430","article-title":"Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction","volume":"152","author":"Ramsay","year":"2007","journal-title":"Br J Pharm"},{"key":"R7-20250601","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bpa.2018.06.002","article-title":"Perioperative implications of common and newer psychotropic medications used in clinical practice","volume":"32","author":"Kaye","year":"2018","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"R8-20250601","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/bjaceaccp\/mkq008","article-title":"Lithium: mimicry, mania, and muscle relaxants","volume":"10","author":"Flood","year":"2010","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"R9-20250601","article-title":"Neurotoxicity with combined use of lithium and haloperidol decanoate","volume":"15","author":"Colvard","year":"2013","journal-title":"Prim Care Companion CNS Disord"},{"key":"R10-20250601","doi-asserted-by":"crossref","first-page":"161","DOI":"10.15420\/aer.2019.8.3.G1","article-title":"British Heart Rhythm Society clinical practice guidelines on the management of patients developing QT prolongation on antipsychotic medication","volume":"8","author":"Lambiase","year":"2019","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"R11-20250601","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.2147\/TCRM.S139545","article-title":"Safinamide in the management of patients with Parkinson's disease not stabilized on levodopa: a review of the current clinical evidence","volume":"14","author":"Bette","year":"2018","journal-title":"Therap Clin Risk Manage"},{"key":"R12-20250601","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/bja\/aef268","article-title":"Parkinson's disease and anaesthesia","volume":"89","author":"Nicholson","year":"2002","journal-title":"Br J Anaesth"},{"key":"R13-20250601","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/00000542-198805000-00043","article-title":"Sedation for patients with Parkinson's disease undergoing opthalmologic surgery","volume":"68","author":"Stone","year":"1988","journal-title":"Anesthesiology"},{"key":"R14-20250601","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1017\/cjn.2020.211","article-title":"A pragmatic approach to the perioperative management of Parkinson's disease","volume":"48","author":"Lenka","year":"2020","journal-title":"Can J Neurol Sci"},{"key":"R15-20250601","first-page":"15","article-title":"Emergencies and critical issues in Parkinson's disease","volume":"20","author":"Simonet","year":"2020","journal-title":"Pract Neurol"},{"key":"R16-20250601","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/00000542-200606000-00029","article-title":"Propofol-induced dyskinesias controlled with dexmedetomidine during deep brain stimulation surgery","volume":"104","author":"Deogaonkar","year":"2006","journal-title":"Anesthesiology"},{"key":"R17-20250601","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ciresp.2010.12.012","article-title":"Perioperative management of Parkinson's disease","volume":"89","author":"Mariscal","year":"2011","journal-title":"Cirug\u00eda Espa\u00f1ola (Engl Ed)"},{"key":"R19-20250601","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000506868","article-title":"Acute and persistent withdrawal syndromes following discontinuation of psychotropic medications","volume":"89","author":"Cosci","year":"2020","journal-title":"Psychother Psychosom"},{"key":"R20-20250601","first-page":"355","article-title":"Antidepressant withdrawal and rebound phenomena","volume":"116","author":"Henssler","year":"2019","journal-title":"Deutsches \u00c4rzteblatt Int"},{"key":"R21-20250601","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.4088\/JCP.11m07607","article-title":"Antidepressive treatment with monoamine oxidase inhibitors and the occurrence of intraoperative hemodynamic events: a retrospective observational cohort study","volume":"73","author":"van Haelst","year":"2012","journal-title":"J Clin Psychiatry"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000001041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T22:08:22Z","timestamp":1748815702000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000001041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,22]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0000000000001041","relation":{},"ISSN":["0952-7907","1473-6500"],"issn-type":[{"value":"0952-7907","type":"print"},{"value":"1473-6500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,22]]}}}